i3 preview on i3connect-app-deployment-7dd45bc68b-bnp54 ((https://preview.i3connect.com/))
You are viewing a limited version of this profile. To access i3's full capabilities.
Plantible Foods
Save
Company logo (jpg or png)
Parent company

Short description

Developer of a plant-based protein alternative

Founded in 2016
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector alternative proteins

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters San Diego, CA San Diego, United States
Address
City
State
Zip
Country

Parent Companies

Updated by at on 04/02/2025

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
10/23/2023
ICL ICL
To create a clean label alternative to methylcellulose, a chemically modified binder commonly used in meat alternatives.
View source    
Confirmed by ICL
Development Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
09/09/2021 Piva Capital Piva Capital , Astanor Ventures Astanor Ventures , CJ CheilJedang CJ CheilJedang , Good Friends Good Friends , Bradley Horowitz Bradley Horowitz , Trevor Martin Trevor Martin , Chris Bryson Chris Bryson , Vectr Ventures Vectr Ventures , Lerer Hippeau Ventures Lerer Hippeau Ventures , 1894 Capital 1894 Capital , FTW Ventures FTW Ventures , Unshackled Ventures Unshackled Ventures (12)
Post-money valuation of
Over the past year, the company has scaled its production capacity by 150x by building out a small pilot plant and hired 11 more people, bringing the team to a total of 16. With the money raised the company will build its first commercial facility to launch and commercialize its product in 2022. Funding amount disclosed via regulatory filing.
Series A $26,840,947
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font